← Insider buys

John S. Montalbano has bought ABCL on 9 days since Dec 2020

Director at AbCellera Biologics Inc.

SEC CIK 0001834423 · Filings on SEC.gov ↗

$1.5MBought
$0Sold
Aug 18Last buy

John S. Montalbano's record

3 months after each buy, from the first price a copier could get.

+21.2%Average
+18.4 ptsVs S&P 500
4 of 8Higher

8 buys since 2020 with 3 months of prices.

Every filing

9 filings since Dec 2020, newest first

About John S. Montalbano

John S. Montalbano

John S. Montalbano is an experienced Canadian business executive and board director. He has served as an independent director of AbCellera Biologics Inc. since 2020 and chairs the company’s Audit Committee.( He is also a principal of Tower Beach Capital Ltd. and serves on several boards, including the Canada Pension Plan Investment Board, Aritzia Inc., Nicola Wealth, Eupraxia Pharmaceuticals Inc., and the Asia Pacific Foundation of Canada.(

Earlier in his career, Mr. Montalbano was Vice Chair of RBC Wealth Management and CEO of RBC Global Asset Management, which at his retirement in 2015 managed about $370 billion in assets.( He was also President of Phillips, Hager & North Investment Management. His education includes a Bachelor of Commerce with Honours from the University of British Columbia and a Chartered Financial Analyst designation; he has also received an honorary Doctor of Letters from Emily Carr University of Art and Design.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.